Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Autosomal dominant polycystic kidney disease, caused by mutations in the PKD1 gene, is characterized by progressive deterioration of kidney function due to the formation of thousands of cysts leading to kidney failure in mid-life or later. How cysts develop and grow is currently unknown, although extensive research revealed a plethora of cellular changes in cyst lining cells. We have constructed a tamoxifen-inducible, kidney epithelium-specific Pkd1-deletion mouse model. Upon administration of tamoxifen to these mice, a genomic fragment containing exons 2-11 of the Pkd1-gene is specifically deleted in the kidneys and cysts are formed. Interestingly, the timing of Pkd1-deletion has strong effects on the phenotype. At 1 month upon gene disruption, adult mice develop only a very mild cystic phenotype showing some small cysts and dilated tubules. Young mice, however, show massive cyst formation. In these mice, at the moment of gene disruption, cell proliferation takes place to elongate the nephron. Our data indicate that Pkd1 gene deficiency does not initiate sufficient autonomous cell proliferation leading to cyst formation and that additional stimuli are required. Furthermore, we show that one germ-line mutation of Pkd1 is already associated with increased proliferation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, mutations in the Pkd1 gene are known to cause cysts to slowly form in the kidney [41].”
From Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease (2023) · cites this paper as [41]
Citations
Cites
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
Nauli, S. M., Alenghat, F. J., Luo, Y., Williams, E., Vassilev, P., Li, X., Elia, A. E. H., Lu, W., Brown, E. M., Quinn, S. J., et al. (2003) · Nature Genetics · doi:10.1038/ng1076 · Cited by 2,057
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · cited 2×
“Partial or complete excision of the loxP-flanked DNA sequences occurred by crossbreeding clone no. 18-derived mice with EIIaCre-mice (43), and the generated mice with the Pkd1nl, the Pkd1lox, and the Pkd1del2 – 11 alleles were further bred (Fig.”
BackgroundWilson, P. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022161 · Cited by 916
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents
Hanaoka, K., Qian, F., Boletta, A., Bhunia, A. K., Piontek, K., Tsiokas, L., Sukhatme, V. P., Guggino, W. B., & Germino, G. G. (2000) · Nature · doi:10.1038/35050128 · Cited by 818
Qian, F., Watnick, T. J., Onuchic, L. F., & Germino, G. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81793-6 · Cited by 615
Somatic Inactivation of Pkd2 Results in Polycystic Kidney Disease
Wu, G., D'Agati, V., Cai, Y., Markowitz, G., Park, J. H., Reynolds, D. M., Maeda, Y., Le, T. C., Hou, H., Kucherlapati, R., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81570-6 · Cited by 570
Defective planar cell polarity in polycystic kidney disease
Fischer, E., Legue, E., Doyen, A., Nato, F., Nicolas, J.-F., Torres, V., Yaniv, M., & Pontoglio, M. (2006) · Nature Genetics · doi:10.1038/ng1701 · Cited by 537
Homo- and heterodimeric interactions between the gene products of PKD1 and PKD 2
Tsiokas, L., Kim, E., Arnould, T., Sukhatme, V. P., & Walz, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6965 · Cited by 476
Bhunia, A. K., Piontek, K., Boletta, A., Liu, L., Qian, F., Xu, P.-N., Germino, F. J., & Germino, G. G. (2002) · Cell · doi:10.1016/s0092-8674(02)00716-x · Cited by 454
Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation
Lu, W., Peissel, B., Babakhanlou, H., Pavlova, A., Geng, L., Fan, X., Larson, C., Brent, G., & Zhou, J. (1997) · Nature Genetics · doi:10.1038/ng1097-179 · Cited by 451
González-Perrett, S., Kim, K., Ibarra, C., Damiano, A. E., Zotta, E., Batelli, M., Harris, P. C., Reisin, I. L., Arnaout, M. A., & Cantiello, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1182 · Cited by 447
The Ion Channel Polycystin-2 Is Required for Left-Right Axis Determination in Mice
Pennekamp, P., Karcher, C., Fischer, A., Schweickert, A., Skryabin, B., Horst, J., Blum, M., & Dworniczak, B. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00869-2 · Cited by 425
Cardiac defects and renal failure in mice with targeted mutations in Pkd2
Wu, G., Markowitz, G. S., Li, L., D'Agati, V. D., Factor, S. M., Geng, L., Tibara, S., Tuchman, J., Cai, Y., Hoon Park, J., et al. (2000) · Nature Genetics · doi:10.1038/71724 · Cited by 399
Yamaguchi, T., Wallace, D. P., Magenheimer, B. S., Hempson, S. J., Grantham, J. J., & Calvet, J. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405079200 · Cited by 353
Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease
Leeuwen, I. S. L.-V., Dauwerse, J. G., Baelde, H. J., Leonhard, W. N., van de Wal, A., Ward, C. J., Verbeek, S., DeRuiter, M. C., Breuning, M. H., de Heer, E., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh336 · Cited by 352
Self-citationPolycystin 1 is required for the structural integrity of blood vessels
Kim, K., Drummond, I., Ibraghimov-Beskrovnaya, O., Klinger, K., & Arnaout, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040550097 · Cited by 338
Epithelial-Specific Cre/lox Recombination in the Developing Kidney and Genitourinary Tract
Shao, X., Somlo, S., & Igarashi, P. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016444.90348.50 · Cited by 330
Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene
Boulter, C., Mulroy, S., Webb, S., Fleming, S., Brindle, K., & Sandford, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211191098 · Cited by 309
Genetic Heterogeneity of Polycystic Kidney Disease in Europe1
Peters, D. J. M., & Sandkuijl, L. A. (2015) · Contributions to Nephrology · doi:10.1159/000421651 · Cited by 282
Self-citationLong-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine
Bukanov, N. O., Smith, L. A., Klinger, K. W., Ledbetter, S. R., & Ibraghimov-Beskrovnaya, O. (2006) · Nature · doi:10.1038/nature05348 · Cited by 276
Autosomal Dominant Polycystic Kidney Disease—More Than a Renal Disease
Gabow, P. A. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80051-5 · Cited by 260
Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells
Qian, Q., Hunter, L. W., Li, M., Marin-Padilla, M., Prakash, Y. S., Somlo, S., Harris, P. C., Torres, V. E., & Sieck, G. C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg190 · Cited by 181
Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease
Ravine, D., Forrest, S. M., Sheffield, L. J., Danks, D. M., Walker, R. G., Kincaid-Smith, P., Gibson, R. N., Richards, R. I., & Friend, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)92503-8 · Cited by 178
Pritchard, L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2617 · Cited by 164
Proliferative activity of cyst epithelium in human renal cystic diseases.
Nadasdy, T., Laszik, Z., Lajoie, G., Blick, K. E., Wheeler, D. E., & Silva, F. G. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v571462 · Cited by 161
Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes
Lu, W., Fan, X., Basora, N., Babakhanlou, H., Law, T., Rifai, N., Harris, P. C., Perez-Atayde, A. R., Rennke, H. G., & Zhou, J. (1999) · Nature Genetics · doi:10.1038/5944 · Cited by 160
Overexpression of PKD1 Causes Polycystic Kidney Disease
Thivierge, C., Kurbegovic, A., Couillard, M., Guillaume, R., Côté, O., & Trudel, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1538-1548.2006 · Cited by 156
EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats
Torres, V. E., Sweeney, W. E., Wang, X., Qian, Q., Harris, P. C., Frost, P., & Avner, E. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00256.x · Cited by 144
Jiang, S., Chiou, Y., Wang, E., Lin, H.-K., Lin, Y.-T., Chi, Y.-C., Wang, C. L., Tang, M., & Li, H. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050342 · Cited by 132
Nishio, S., Hatano, M., Nagata, M., Horie, S., Koike, T., Tokuhisa, T., & Mochizuki, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522850 · Cited by 131
Shao, X., Johnson, J. E., Richardson, J. A., Hiesberger, T., & Igarashi, P. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016443.50138.cd · Cited by 123
Germino, G. G. (2005) · Nature Genetics · doi:10.1038/ng0505-455 · Cited by 110
Boca, M., Distefano, G., Qian, F., Bhunia, A. K., Germino, G. G., & Boletta, A. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050534 · Cited by 100
Parker, E., Newby, L. J., Sharpe, C. C., Rossetti, S., Streets, A. J., Harris, P. C., O'Hare, M. J., & Ong, A. C. M. (2007) · Kidney International · doi:10.1038/sj.ki.5002229 · Cited by 89
Chang, M., Parker, E., Ibrahim, S., Shortland, J. R., Nahas, M. E., Haylor, J., & Ong, A. C. M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl150 · Cited by 88
Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats
Torres, V. E., Sweeney, W. E., Wang, X., Qian, Q., Harris, P. C., Frost, P., & Avner, E. D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00952.x · Cited by 82
Hassane, S., Claij, N., Leeuwen, I. S. L., van Munsteren, J. C., van Lent, N., Hanemaaijer, R., Breuning, M. H., Peters, D. J. M., & DeRuiter, M. C. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149252 · Cited by 77
Self-citationLantinga‐van Leeuwen, I. S., Leonhard, W. N., van de Wal, A., Breuning, M. H., Verbeek, S., de Heer, E., & Peters, D. J. M. (2006) · genesis · doi:10.1002/dvg.20207 · Cited by 72
Self-citationRamasubbu, K., Gretz, N., & Bachmann, S. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v96937 · Cited by 70
Torres, V. E., Cowley, B. D., Branden, M. G., Yoshida, I., & Gattone, V. H. (2001) · Nephron Experimental Nephrology · doi:10.1159/000052609 · Cited by 45
Depletion of PKD1 by an antisense oligodeoxynucleotide induces premature G1/S-phase transition
Kim, H., Bae, Y., Jeong, W., Ahn, C., & Kang, S. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201136 · Cited by 38
Allen, E., Piontek, K. B., Garrett-Mayer, E. S., García-González, M. Á., Gorelick, K. L., & Germino, G. G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi421 · Cited by 31
Effects of Potassium Citrate/Citric Acid Intake in a Mouse Model of Polycystic Kidney Disease
Tanner, G. A., Vijayalakshmi, K., & Tanner, J. A. (2000) · The Nephron journals/Nephron journals · doi:10.1159/000045588 · Cited by 19
Cited by
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Bergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationHarris, P. C., & Torres, V. E. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101707.125712 · Cited by 801
“Recent studies of conditional knockouts of Pkd1 show that inactivation before postnatal day 13 results in rapidly progressive cystic disease whereas later inactivation results in a much milder course, indicating a developmental switch that may be associated with normal downregulation of the protein at that time (21,22…”
Autosomal dominant polycystic kidney disease: the last 3 years
Torres, V. E., & Harris, P. C. (2009) · Kidney International · doi:10.1038/ki.2009.128 · Cited by 590
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
Hopp, K., Ward, C. J., Hommerding, C. J., Nasr, S. H., Tuan, H.-F., Gainullin, V. G., Rossetti, S., Torres, V. E., & Harris, P. C. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64313 · Cited by 442
“The role of proliferation to cyst expansion in ADPKD is a controversial one, but when analysis is limited to tubular/cystic epithelia, increased cell division clearly occurs (36, 37, 79).”
Metadata
- Authors
- Lantinga-van Leeuwen, I. S., Leonhard, W. N., van der Wal, A., Breuning, M. H., de Heer, E., & Peters, D. J. M.
- Corresponding author
- Peters, D. J.M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-09-12
- Volume
- 16
- Issue
- 24
- Pages
- 3188-3196
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2115962978
- Cited by
- 223
- References
- 43
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 12 · 2022: 11 · 2021: 12 · 2020: 12 · 2019: 11 · 2018: 10 · 2017: 12 · 2016: 11 · 2015: 17 · 2014: 11 · 2013: 7 · 2012: 11
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- autosomal dominant polycystic kidney disease, PKD1 gene, PKD1, kidney cyst formation, cell proliferation, germline mutations, mouse model
- MeSH terms
- Animals, Animals, Newborn, Animals, Suckling, Cysts, Gene Expression Regulation, Kidney, Polycystic Kidney Diseases, Lactation, Mice, Transgenic, Models, Biological, Organ Specificity, Tamoxifen, Time Factors, Gene Deletion, Age of Onset, Germ-Line Mutation, Cell Proliferation, TRPP Cation Channels, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.